New study seeks immune clues to prevent HCMV transmission in pregnancy
NCT ID NCT07477925
First seen Mar 28, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study is for pregnant women who have had a first-time HCMV infection early in pregnancy. Researchers want to find out if certain immune system markers can predict whether the virus will be passed to the baby. They will take blood samples and analyze immune cells, but no new treatments or vaccines are being tested. The goal is to better understand how to protect unborn babies from this common infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN CYTOMEGALOVIRUS (HCMV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, Lombardy, 27100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.